New Key Statistics Module, Z-Score and F-Score
OTCPK:RAMMF Key Ratios
| Market Cap $ M | 9.04 |
| Enterprise Value $ M | 4.17 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.09 |
| Price/Sales | 0.51 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 3.00 |
| EPS (TTM) $ | -- |
| Beneish M-Score | -1.6 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -62.30 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.01 |
| EV-to-EBITDA | 0.01 |
| PEG | -- |
| Shares Outstanding M | 121.80 |
| Net Margin (%) | -194.25 |
| Operating Margin % | -154.48 |
| Pre-tax Margin (%) | -194.03 |
| Quick Ratio | 2.17 |
| Current Ratio | 3.28 |
| ROA % (ttm) | -27.05 |
| ROE % (ttm) | -29.44 |
| ROIC % (ttm) | -27.66 |
| Dividend Yield % | -- |
| Altman Z-Score | -2.65 |
RAMMF Number of Guru Trades
RAMMF Volume of Guru Trades
Gurus Latest Trades with OTCPK:RAMMF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:RAMMF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
RAMM Pharma Corp Insider Transactions
No Available Data
News about OTCPK:RAMMF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers